Literature DB >> 18057386

A 'smart' type of Cushing's syndrome.

A J Razenberg1, J W F Elte, A P Rietveld, H C T van Zaanen, M Castro Cabezas.   

Abstract

Cushing's syndrome results from lengthy and inappropriate exposure to excessive concentrations of either endogenous or exogenous glucocorticoids. This case report describes a patient with a novel type of Cushing's syndrome due to the use of party drugs. A 35-year-old woman had gained 8 kg body weight in 5 months and complained of anxiety. She showed a Cushing-like appearance and mild hypertension (blood pressure, BP 150/95 mmHg). She reported daily use of increasing doses of gamma-hydroxybutyric acid (GHB), a popular party drug. ACTH plasma levels were in the upper normal range (41 ng/l), with normal plasma cortisol (0.36 micromol/l). She showed an abnormal overnight 1 mg dexamethasone suppression test (cortisol 0.38 micromol/l). The urinary excretion of free cortisol in 24 h was also increased (0.47 micromol/24 h). CT scanning of the abdomen showed normal adrenals. After stopping GHB intake she lost 7 kg body weight and her BP normalized (BP 135/80 mmHg). GHB is a popular party drug in the Netherlands, but it is also used as a narcotic and for the treatment of narcolepsy. We hypothesize that GHB may bind to the pituitary gland gamma-aminobutyric acid-B receptors leading to ACTH overproduction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057386     DOI: 10.1530/EJE-07-0538

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Hyperglycaemia and ketosis induced by gamma hydroxybutyrate (GHB).

Authors:  D S H Bell
Journal:  Diabetologia       Date:  2010-04-16       Impact factor: 10.122

3.  Breaking the Taboo: Illicit Drug Use among Adolescents with Type 1 Diabetes Mellitus.

Authors:  Anna M Hogendorf; Wojciech Fendler; Janusz Sieroslawski; Katarzyna Bobeff; Krzysztof Wegrewicz; Kamila I Malewska; Maciej W Przudzik; Malgorzata Szmigiero-Kawko; Beata Sztangierska; Malgorzata Mysliwiec; Agnieszka Szadkowska; Wojciech Mlynarski
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

Review 4.  Toxicological Characterization of GHB as a Performance-Enhancing Drug.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.